EUVIMEDEUVIMED entdecken
Metaanalyse

Renal denervation in hypertension: An updated meta‐analysis of the randomized controlled trials

Sahib Singh iD, Amit Rout, Aakash Garg iD

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30796 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Sahib Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Sinai Hospital of Baltimore, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Blood Pressure, Catheter Ablation, Hypertension, Kidney. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radiofrequency or ultrasound renal denervation (RDN) has shown conflicting results when used as an adjunctive option for hypertension management in randomized controlled trials (RCTs).

Methods

We searched Pubmed, MEDLINE, and other online databases for RCTs comparing RDN versus sham‐control procedures in patients with uncontrolled or resistant hypertension. The endpoints of interest were 24‐h ambulatory (AMB) blood pressure (BP), daytime AMB BP, and office BP. We performed a random‐effects meta‐analysis using the inverse variance method to estimate mean difference (MD) with a 95% confidence interval (CI).

Results

Nine studies with 1643 patients were included in the final analysis. The mean follow‐up was 5 months. As compared with the sham‐controlled group, RDN was associated with a significant decrease in 24‐h AMB BP (systolic [MD −4.20; 95% CI −5.36 to −3.03; p < 0.00001], diastolic [−2.38; −3.42 to −1.35]), and daytime AMB BP (systolic: −5.11; −6.75 to −3.47, diastolic: −2.88; −3.91 to −1.85). Similarly, office BP was reduced with RDN (systolic: −5.46; −7.12 to −3.81; diastolic: −3.17; −4.23 to −2.12) when compared with placebo.

Conclusion

Our meta‐analysis shows that RDN is associated with a significant reduction in the 24‐h AMB BP, daytime AMB BP, and office BP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PressureCatheter AblationHypertensionKidneyRenal ArterySympathectomyUltrasonic TherapyFemaleHumansMaleMiddle AgedAntihypertensive AgentsBlood Pressure Monitoring, AmbulatoryRandomized Controlled Trials as TopicTime FactorsTreatment Outcome

Stichwörter der Autor:innen

hypertensionrenal denervation

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Medicine, Sinai Hospital of Baltimore, Baltimore, Maryland, USA.
  • Division of Cardiology, University of Louisville, Louisville, Kentucky, USA.
  • Cardiology Associates of Schenectady, St. Peter's Health Partners, New York City, New York, USA.

ORCID-Profile: Sahib Singh, Aakash Garg

Zitieren

APA

Singh, S., Rout, A., & Garg, A. (2023). Renal denervation in hypertension: An updated meta‐analysis of the randomized controlled trials. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30796

Vancouver

Singh S, Rout A, Garg A. Renal denervation in hypertension: An updated meta‐analysis of the randomized controlled trials. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30796

BibTeX
@article{Singh2023,
  author = {Singh, Sahib and Rout, Amit and Garg, Aakash},
  title = {Renal denervation in hypertension: An updated meta‐analysis of the randomized controlled trials},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30796}
}
Kostenlos starten →